These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32674030)

  • 1. Impact of intrathecal IgG synthesis on neurological disability in patients with multiple sclerosis.
    Akaishi T; Takahashi T; Fujihara K; Misu T; Nishiyama S; Takai Y; Fujimori J; Abe M; Ishii T; Aoki M; Nakashima I
    Mult Scler Relat Disord; 2020 Oct; 45():102382. PubMed ID: 32674030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis.
    Gasperi C; Salmen A; Antony G; Bayas A; Heesen C; Kümpfel T; Linker RA; Paul F; Stangel M; Tackenberg B; Bergh FT; Warnke C; Weber F; Wiendl H; Wildemann B; Zettl UK; Ziemann U; Zipp F; Tumani H; Gold R; Hemmer B;
    JAMA Neurol; 2019 Jul; 76(7):841-849. PubMed ID: 31034002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal synthesis in particular types of multiple sclerosis.
    Sladkova V; Mares J; Hlustik P; Langova J; Kanovsky P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014; 158(1):124-6. PubMed ID: 23073520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal IgM index correlates with a severe disease course in multiple sclerosis: Clinical and MRI results.
    Ozakbas S; Cinar BP; Özcelik P; Baser H; Kosehasanoğullari G
    Clin Neurol Neurosurg; 2017 Sep; 160():27-29. PubMed ID: 28622533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution.
    Beseler C; Vollmer T; Graner M; Yu X
    PLoS One; 2017; 12(10):e0186842. PubMed ID: 29059249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cut-off evaluation of intrathecal oligoclonal bands of IgM in relapsing-remitting multiple sclerosis; a retrospective study.
    Hvaring C; Alawad N; Salvesen Ø; Hovdal H; White LR; Boullerne AI
    Mult Scler Relat Disord; 2022 Dec; 68():104188. PubMed ID: 36179461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset.
    Puthenparampil M; Federle L; Miante S; Zito A; Toffanin E; Ruggero S; Ermani M; Pravato S; Poggiali D; Perini P; Rinaldi F; Gallo P
    J Neuroinflammation; 2017 Jan; 14(1):11. PubMed ID: 28095856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
    Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
    Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical characteristics and neurophysiologic findings in patients with multiple sclerosis without oligoclonal IgG in cerebrospinal fluid].
    Mesaros S; Drulović J; Lević Z
    Srp Arh Celok Lek; 2003; 131(3-4):122-6. PubMed ID: 14608874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression.
    Lourenco P; Shirani A; Saeedi J; Oger J; Schreiber WE; Tremlett H
    Mult Scler; 2013 Apr; 19(5):577-84. PubMed ID: 22961214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.
    Obradović D; Kataranovski M; Dincić E; Obradović S; Colić M
    Vojnosanit Pregl; 2012 Feb; 69(2):151-6. PubMed ID: 22500369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Findings of cerebrospinal fluid in the diagnosis of multiple sclerosis].
    Drulović J; Stojsavljević N; Dujmović I; Sokić D; Mavra M; Lević Z
    Srp Arh Celok Lek; 1995; 123(7-8):191-3. PubMed ID: 17974427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies.
    Castellazzi M; Contini C; Tamborino C; Fasolo F; Roversi G; Seraceni S; Rizzo R; Baldi E; Tola MR; Bellini T; Granieri E; Fainardi E
    J Neuroinflammation; 2014 Nov; 11():188. PubMed ID: 25391491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased cerebrospinal fluid chitotriosidase index in patients with multiple sclerosis.
    Verbeek MM; Notting EA; Faas B; Claessens-Linskens R; Jongen PJ
    Acta Neurol Scand; 2010 May; 121(5):309-14. PubMed ID: 19925532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chlamydia pneumoniae-specific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms.
    Fainardi E; Castellazzi M; Tamborino C; Seraceni S; Tola MR; Granieri E; Contini C
    J Neurovirol; 2009 Sep; 15(5-6):425-33. PubMed ID: 20053141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.
    Rudick RA; Cookfair DL; Simonian NA; Ransohoff RM; Richert JR; Jacobs LD; Herndon RM; Salazar AM; Fischer JS; Granger CV; Goodkin DE; Simon JH; Bartoszak DM; Bourdette DN; Braiman J; Brownscheidle CM; Coats ME; Cohan SL; Dougherty DS; Kinkel RP; Mass MK; Munchsauer FE; O'Reilly K; Priore RL; Whitham RH
    J Neuroimmunol; 1999 Jan; 93(1-2):8-14. PubMed ID: 10378864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis.
    Castillo-Villalba J; Gil-Perotín S; Gasque-Rubio R; Cubas-Nuñez L; Carratalà-Boscà S; Alcalá C; Quintanilla-Bordás C; Pérez-Miralles F; Ferrer C; Cañada Martínez A; Tortosa J; Solís-Tarazona L; Campos L; Leivas A; Laíz Marro B; Casanova B
    Front Immunol; 2022; 13():827738. PubMed ID: 35330910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal Fluid Findings in 541 Patients With Clinically Isolated Syndrome and Multiple Sclerosis: A Monocentric Study.
    Berek K; Bsteh G; Auer M; Di Pauli F; Zinganell A; Berger T; Deisenhammer F; Hegen H
    Front Immunol; 2021; 12():675307. PubMed ID: 34220821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid markers in incident pediatric-onset multiple sclerosis: a nationwide study.
    McKay KA; Wickström R; Hillert J; Karrenbauer VD
    Sci Rep; 2021 Sep; 11(1):18528. PubMed ID: 34535701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Magnetic resonance findings in the brain of patients with multiple sclerosis without oligoclonal bands in the cerebrospinal fluid].
    Mesaroc S; Drulović J; Lević Z; Perić V
    Srp Arh Celok Lek; 2003; 131(1-2):31-5. PubMed ID: 14608859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.